Chi-Hang Yee, MBBS, MD, FRCSEd(Urol), FHKAM(Surgery), The Chinese University of Hong Kong, Hong Kong, China, discusses how concomitant prostate cancer in bladder cancer patients affects the treatment and prognosis of patients. This interview took place at the EAU congress in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.